Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-3.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-3.0%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 97.34% |
| 2024 | -139.11% |
| 2023 | 204.74% |
| 2022 | 106.71% |
| 2021 | -52.93% |
| 2020 | -26.65% |
| 2019 | -50.98% |
| 2018 | -44.91% |
| 2017 | -5.40% |
| 2016 | 2.32% |